Products

We are dedicated to researching and developing novel therapeutics for the treatment of cancer, autoimmune, cardiovascular diseases, and other serious unmet medical needs

Process and Manufacture

We have established a comprehensive quality management system in compliance with requirements applicable to and enforced by global competent authorities

Explore further

Company News

Bio-Thera Solutions Announces FDA Accepts Biologics License A

Bio-Thera Solutions (SHA: 688177), a commercial-stage biopharmaceuticalcompany, today announced that the U.S. Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) for...

Bio-Thera Solutions Announces FDA Accepts Biologics License A

Bio-Thera Solutions (SHA: 688177), a commercial-stage biopharmaceuticalcompany, today announced that the U.S. Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) for...

Bio-Thera Solutions Partners with Biomm to Market BAT1706 in

GUANGZHOU, China and SAO PAULO, Brazil ---(Businesswire)--- Bio-Thera Solutions (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, ...